Document is current

Article History

Received: 26 August 2022

Accepted: 13 February 2023

First Online: 16 March 2023

Competing interests

: Siemens Healthineers partially supported this study by providing the Laptop and the software with which the study was conducted. The software used was developed in collaboration between Siemens Healthineers and the investigating hospital, whereby the development was funded by Siemens Healthineers. Siemens Healthineers was not involved in the study design, data collection, data analysis, and data interpretation. Siemens Healthineers did not have access to the data sets of the validation collective and were not involved in the statistical analysis of the study. Johannes Haubold has received a speaker honorarium from Siemens Healthineers, Boston Scientific and Novo Nordisk Pharma GmbH outside of the submitted work. Ke Zeng and Sepehr Farhand are employees of Siemens Healthineers. Sarah Stalke is an employee of Georg Thieme Verlag KG. The DFG (German Research Foundation) supported Clinician Scientist Program of the University Medicine Essen Clinician Scientist Academy (UMEA) (FU 356/12-1) provided financial support to Johannes Haubold and Denise Bos. The DFG played no part in the study's design, data collecting, interpretation, analysis, or report writing. The respective authors had full access to all data in the study and had the final responsibility for the decision to submit the manuscript for publication. There was no further conflict of interest.